Switch theme
Sign up to access all valuation multiples
Ambu AS is a Denmark based company providing single-use flexible endoscopes and is dedicated to optimizing hospital workflows and improving patient care. The company has created medtech solutions like resuscitators, anaesthesia masks, and electrodes and operates R&D, manufacturing and sales in Europe, North America and Rest of the world.
1937
5.2K+
LTM Revenue $884M
LTM EBITDA $172M
$4.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ambu has a last 12-month revenue (LTM) of $884M and a last 12-month EBITDA of $172M.
In the most recent fiscal year, Ambu achieved revenue of $812M and an EBITDA of $103M.
Ambu expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ambu valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $884M | XXX | $812M | XXX | XXX | XXX |
| Gross Profit | $484M | XXX | $482M | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 59% | XXX | XXX | XXX |
| EBITDA | $172M | XXX | $103M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 13% | XXX | XXX | XXX |
| EBIT | $121M | XXX | $97.1M | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $81.0M | XXX | $35.4M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ambu's stock price is DKK 101 (or $15).
Ambu has current market cap of DKK 27.0B (or $4.1B), and EV of DKK 26.9B (or $4.1B).
See Ambu trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.1B | $4.1B | XXX | XXX | XXX | XXX | $0.30 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ambu has market cap of $4.1B and EV of $4.1B.
Ambu's trades at 4.8x EV/Revenue multiple, and 33.0x EV/EBITDA.
Equity research analysts estimate Ambu's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ambu has a P/E ratio of 50.2x.
See valuation multiples for Ambu and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4.1B | XXX | $4.1B | XXX | XXX | XXX |
| EV (current) | $4.1B | XXX | $4.1B | XXX | XXX | XXX |
| EV/Revenue | 4.6x | XXX | 4.8x | XXX | XXX | XXX |
| EV/EBITDA | 23.5x | XXX | 33.0x | XXX | XXX | XXX |
| EV/EBIT | 33.4x | XXX | 38.2x | XXX | XXX | XXX |
| EV/Gross Profit | 8.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 50.2x | XXX | 77.4x | XXX | XXX | XXX |
| EV/FCF | 49.3x | XXX | 50.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmbu's last 12 month revenue growth is 12%
Ambu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Ambu's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ambu's rule of X is 50% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ambu and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 21% | XXX | 42% | XXX | XXX | XXX |
| Rule of 40 | 25% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 50% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 29% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ambu acquired XXX companies to date.
Last acquisition by Ambu was XXXXXXXX, XXXXX XXXXX XXXXXX . Ambu acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ambu founded? | Ambu was founded in 1937. |
| Where is Ambu headquartered? | Ambu is headquartered in Denmark. |
| How many employees does Ambu have? | As of today, Ambu has 5.2K+ employees. |
| Who is the CEO of Ambu? | Ambu's CEO is Ms. Britt Meelby Jensen. |
| Is Ambu publicy listed? | Yes, Ambu is a public company listed on CSE. |
| What is the stock symbol of Ambu? | Ambu trades under AMBU B ticker. |
| When did Ambu go public? | Ambu went public in 1993. |
| Who are competitors of Ambu? | Similar companies to Ambu include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Ambu? | Ambu's current market cap is $4.1B |
| What is the current revenue of Ambu? | Ambu's last 12 months revenue is $884M. |
| What is the current revenue growth of Ambu? | Ambu revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Ambu? | Current revenue multiple of Ambu is 4.6x. |
| Is Ambu profitable? | Yes, Ambu is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ambu? | Ambu's last 12 months EBITDA is $172M. |
| What is Ambu's EBITDA margin? | Ambu's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Ambu? | Current EBITDA multiple of Ambu is 23.5x. |
| What is the current FCF of Ambu? | Ambu's last 12 months FCF is $82.3M. |
| What is Ambu's FCF margin? | Ambu's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Ambu? | Current FCF multiple of Ambu is 49.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
